HomeAI · summaries
Storia in 2 fonti
Longevity Startups Have a Conundrum: Can They Sell Longevity Drugs?
In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs that can reverse aging. NewLimit, a cell reprogramming company co-founded in 2022 by Coinbase CEO Brian Armstrong, announced earlier this month that it had raised another ...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
The New Billionaire Bet Isn't AI — It's Longevity Biotech
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping the future of aging research.
- ·
theinformation.com
Longevity Startups Have a Conundrum: Can They Sell Longevity Drugs?
In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs that can reverse aging. NewLimit, a cell…